Rasonque’s Lightning Approval Validates Druckenmiller’s Bet on Revolution Medicines

Life Science

Clinical-Stage Biotechnology Company Biohaven Sees Dual Positive Developments During the Week

Life Science

J&J’s 64-Year Dividend Streak Reinforces ‘Sleep-Well’ Stock Status

Life Science

Novo Nordisk’s Weight-Loss Oral Drug Makes New Progress in China Approval

Life Science

Billionaire Loads Up on Revolution Medicines, the Upside Could Be More Than 7%

Life Science

Beyond Eli Lilly and Novo Nordisk: Overlooked Opportunities in the GLP-1 Race

Life Science

mRNA Cancer Vaccine Trial Succeeds, Biotech Sector Sees Catalyst

Life Science

Shattuck Labs Jumps as Two Analysts Start Bullish Coverage

Life Science

Medicare Part D Subsidy Expires Next Year, Retirees Should Watch for Premium Changes

Life Science

Pharmacy Drag and Consumer Weakness Slow Wal-Mart’s Growth, with E-Commerce and Membership Businesses Becoming Future Highlights

Consumer Goods, Life Science

Cannabis Consolidation Wave Accelerates, ETF Allocation Value Stands Out

Cannabis

Moderna Gains Strong Recovery Momentum, Pipeline Breakthroughs and the Long-Term Logic Behind a $10 Billion Market Value

Life Science

With Price-Increase Clauses, These Two Drug Distributors Can Withstand ‘Trumpflation’

Life Science

Eli Lilly Builds a Weight-Loss Drug Empire, Valuation Chases SpaceX

Life Science

Moderna Surges Nearly 60%, But Clinical Win Has Yet to Reverse Financial Slide

Life Science